Stanford Hospitals and Clinics

Stanford, California 94305

1 studies enrolling now · 12 studies all time

What they study most

Acquired Aplastic Anemia, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia, Advanced Unresectable Solid Tumors, Alcohol Withdrawal Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Aortic Aneurysm, Abdominal, BRAF-mutated Tumors, Breast Cancer, Chronic Myeloid Leukemia, Extent IV Thoracoabdominal

Studies at this site

• Zenith® Fenestrated+ Clinical Study — Recruiting now
• Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) — Completed
• A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors — Completed
• Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients — Completed
• The "Stanford Integrated Psychosocial Assessment for Transplant" (SIPAT) — Completed
• Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202) — Completed
• Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia — Completed
• Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML — Completed
• High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases — Withdrawn before enrolling
• Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery — Completed
• Contrast Media Reduction and Removal in Patients With Chronic Kidney Disease (CKD) (PRESERV) — Stopped early
• The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS) — Completed